Hiroko Mataki
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- Microbial metabolism and enzyme function
Papers in
-
- Circular RNAs in diseases 3
- Microbial metabolism and enzyme function 2
- RNA modifications and cancer 2
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 5
- Co-authors
- Naohiko Seki (12 shared papers)Keiko Mizuno (9 shared papers)Hiromasa Inoue (8 shared papers)Yusuke Goto (8 shared papers)Tomohiro Kumamoto (7 shared papers)Kazuto Kamikawaji (6 shared papers)Hideki Enokida (6 shared papers)Masayuki Nakagawa (6 shared papers)
- Journals
- International Journal of Oncology (4 papers)Oncotarget (1 paper)British Journal of Cancer (1 paper)FEBS Letters (1 paper)Journal of Human Genetics (5 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Hiroko Mataki
16 papers receiving 776 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 472
- Molecular Biology 500
- Pulmonary and Respiratory Medicine 85
- Pathology and Forensic Medicine 42
- Oncology 62
Countries citing papers authored by Hiroko Mataki
This map shows the geographic impact of Hiroko Mataki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Mataki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Mataki more than expected).
Fields of papers citing papers by Hiroko Mataki
This network shows the impact of papers produced by Hiroko Mataki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Mataki. The network helps show where Hiroko Mataki may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Mataki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 109 | |
| 2 | 2014 | 74 | |
| 3 | 2017 | 65 | |
| 4 | 2016 | 65 | |
| 5 | 2014 | 61 | |
| 6 | 2015 | 57 | |
| 7 | 2016 | 56 | |
| 8 | 2016 | 54 | |
| 9 | 2016 | 53 | |
| 10 | 2014 | 51 | |
| 11 | 2016 | 47 | |
| 12 | 2014 | 40 | |
| 13 | 2010 | 27 | |
| 14 | ICAM-1 expression and cellular injury in cultured endothelial cells under hypoxia/reoxygenation. | 1994 | 16 |
| 15 | [A case of pulmonary toxocariasis successfully treated with ivermectin]. | 2011 | 4 |
| 16 | 2012 | 3 |
About Hiroko Mataki
Hiroko Mataki is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology, having authored 16 papers that have together received 782 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers), Cancer Mechanisms and Therapy (3 papers), Circular RNAs in diseases (3 papers), Microbial metabolism and enzyme function (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), RNA modifications and cancer (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (472 citations), Molecular Biology (500 citations), Pulmonary and Respiratory Medicine (85 citations), Pathology and Forensic Medicine (42 citations) and Oncology (62 citations). Hiroko Mataki has collaborated with scholars based in Japan and United States. Frequent co-authors include Naohiko Seki, Keiko Mizuno, Hiromasa Inoue, Yusuke Goto, Tomohiro Kumamoto, Kazuto Kamikawaji, Hideki Enokida, Masayuki Nakagawa, Rika Nishikawa and Takeshi Chiyomaru. Their work appears in journals such as International Journal of Oncology, Oncotarget, British Journal of Cancer, FEBS Letters and Journal of Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.